login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
COLLEGIUM PHARMACEUTICAL INC (COLL) Stock News
NASDAQ:COLL -
US19459J1043
-
Common Stock
38.58
USD
-0.19 (-0.49%)
Last: 8/26/2025, 8:22:42 PM
38.58
USD
0 (0%)
After Hours:
8/26/2025, 8:22:42 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
COLL Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Chartmill
Collegium Pharmaceutical Inc (NASDAQ:COLL) Reports Record Q2 2025 Earnings and Raises Full-Year Guidance
2 days ago - By: Collegium Pharmaceutical, Inc.
Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting
2 days ago - By: Collegium Pharmaceutical, Inc.
Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting
16 days ago - By: Yahoo Finance
- Mentions:
MS
CMI
HSBC
LINE
...
Arm initiated, Adobe downgraded: Wall Street's top analyst calls
20 days ago - By: The Motley Fool
Collegium (COLL) Q2 Revenue Jumps 29%
20 days ago - By: Zacks Investment Research
Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics
20 days ago - By: Zacks Investment Research
- Mentions:
KPTI
Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates
20 days ago - By: Collegium Pharmaceutical, Inc.
Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook
20 days ago - By: Collegium Pharmaceutical, Inc.
Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook
20 days ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
21 days ago - By: Zacks Investment Research
- Mentions:
NOTV
Inotiv, Inc. (NOTV) Reports Q3 Loss, Tops Revenue Estimates
22 days ago - By: Zacks Investment Research
- Mentions:
ZVRA
Zevra Therapeutics (ZVRA) Reports Next Week: Wall Street Expects Earnings Growth
a month ago - By: Collegium Pharmaceutical, Inc.
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
a month ago - By: Collegium Pharmaceutical, Inc.
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
2 months ago - By: MarketBeat
- Mentions:
FITB
ENVX
THO
DRI
5 Hot Stocks With Summer Buybacks You Can Cash In On
2 months ago - By: Collegium Pharmaceutical, Inc.
Collegium Announces $150 Million Share Repurchase Program
2 months ago - By: FN Media Group LLC
- Mentions:
TEVA
EBS
PFE
NTRB
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
3 months ago - By: Collegium Pharmaceutical, Inc.
Collegium to Participate in Upcoming Investor Conferences
3 months ago - By: Collegium Pharmaceutical, Inc.
Collegium to Participate in Upcoming Investor Conferences
4 months ago - By: Collegium Pharmaceutical, Inc.
Collegium Announces $25 Million Accelerated Share Repurchase Program
4 months ago - By: Collegium Pharmaceutical, Inc.
Collegium Announces $25 Million Accelerated Share Repurchase Program
4 months ago - By: Zacks Investment Research
Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics
4 months ago - By: Zacks Investment Research
- Mentions:
AQST
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates
Please enable JavaScript to continue using this application.